Mode
Text Size
Log in / Sign up

Chronic pain linked to 7.5-fold increase in severe depressive symptoms in UK Biobank analysisDoes chronic pain make depression worse? New data says yes, and the link goes both ways

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider genetic and symptom-specific links between chronic pain and depression in comorbid cases.

This observational study analyzed data from 142,688 age- and sex-matched participants in the UK Biobank cohort. It compared individuals with chronic pain to those without, assessing depressive symptom severity via PHQ-9 and exploring genetic correlations and causal effects using GWAS summary statistics and two-sample Mendelian randomisation.

Main results showed chronic pain was associated with a 7.50-fold increase in severe depressive symptoms and at least 2.79 times higher prevalence of all individual depressive symptoms. Genetic correlations were positive, with rg = 0.59 between chronic pain and major depressive disorder (MDD) and rg = [0.24, 0.55] for all depressive symptoms. Mendelian randomisation indicated bidirectional causal associations: chronic pain increased risk of MDD (OR = 1.85, pFDR < 0.001) and anhedonia (OR = 1.60, pFDR < 0.001), while MDD (beta = 0.17, pFDR < 0.001) and anhedonia (beta = 0.08, pFDR = 0.005) increased risk of chronic pain. Unidirectional effects from chronic pain were found for appetite/weight gain (OR = 1.90, pFDR = 0.022), appetite/weight loss (OR = 1.63, pFDR = 0.005), concentration problems (OR = 1.63, pFDR = 0.044), and suicidal thoughts (OR = 1.46, pFDR = 0.021). Genetic liability to concentration problems was associated with a lower risk of chronic pain (beta = -0.04, pFDR = 0.022).

Safety and tolerability data were not reported. Key limitations include that prevalence of individual depressive symptoms in chronic pain and genetic and causal associations remain poorly characterised, as noted in the background. Practice relevance suggests shared genetic architecture and symptom-specific causal pathways, particularly involving anhedonia, may highlight targets for treating comorbid chronic pain and depression, but these findings are based on genetic and observational data without direct clinical application.

Imagine living with constant pain and wondering why you feel so down. A new analysis of 142,688 people in the UK Biobank suggests you are not alone in that feeling. The study found that people with chronic pain were 7.5 times more likely to have severe depressive symptoms than those without pain. Every single individual symptom of depression was also at least 2.79 times more common in the pain group.

The research went deeper than just counting symptoms. It looked at the genetic links between pain and depression, finding a strong positive connection. More importantly, it used a method called Mendelian randomization to check for cause and effect. The results showed a two-way street: chronic pain can cause depression, and depression can increase the risk of chronic pain. This bidirectional link was confirmed for major depression and a specific symptom called anhedonia, which is the loss of pleasure.

However, the study also found that pain can cause other issues like trouble concentrating, changes in appetite, and even suicidal thoughts. While these genetic and statistical links are strong, the study authors note that we still do not fully understand how common these specific symptom patterns are in real life. These results come from genetic data and large group averages, so they tell us about shared biology rather than guaranteeing what will happen to any single person.

What this means for you:
Chronic pain and depression fuel each other through shared biology, but genetic links do not predict individual outcomes.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Background Chronic pain and depression are leading causes of disability and frequently co-occur. Depression presents with diverse symptoms, but despite this variability, the prevalence of individual depressive symptoms in chronic pain and the genetic and causal associations linking these traits remain poorly characterised. Methods Using data from 142,688 age- and sex-matched UK Biobank participants, we compared depressive symptom severity levels and item-level Patient Health Questionnaire-9 (PHQ-9) prevalences, spanning affective, cognitive and somatic domains, between participants with and without chronic pain. Using genome-wide association study (GWAS) summary statistics of multisite chronic pain (MCP), major depressive disorder (MDD), and individual symptoms of depression, genetic correlations and bidirectional causal effects between MCP and depressive phenotypes (MDD and individual symptoms) were estimated via linkage disequilibrium score regression (LDSC) and two-sample Mendelian randomisation (MR), respectively. Results Depression (at every severity level) was more common in the chronic pain group compared to controls, with the largest between-group difference for severe symptoms (7.50-fold increase). All individual depressive symptoms were at least 2.79 times as prevalent in chronic pain. Additionally, chronic pain had a significant and positive genetic correlation with MDD (rg = 0.59) and all depressive symptoms (rg = [0.24, 0.55]). MR supported a bidirectional causal association between MCP and MDD (MCP[-&gt;]MDD: OR = 1.85, pFDR < 0.001, MDD[-&gt;]MCP: {beta} = 0.17, pFDR < 0.001). At the symptom level, MR indicated bidirectional effects between MCP and anhedonia (MCP[-&gt;]anhedonia: OR = 1.60, pFDR < 0.001, anhedonia[-&gt;]MCP: {beta} = 0.08, pFDR = 0.005), and unidirectional effects of MCP on appetite/weight gain (OR = 1.90, pFDR = 0.022) and appetite/weight loss (OR = 1.63, pFDR = 0.005), concentration problems (OR = 1.63, pFDR = 0.044), and suicidal thoughts (OR = 1.46, pFDR = 0.021). Additionally, genetic liability to concentration problems was associated with a lower risk of MCP ({beta} = -0.04, pFDR = 0.022). Conclusion Chronic pain is associated with a marked depressive burden spanning all symptom domains. Shared genetic architecture and symptom-specific causal pathways, particularly involving anhedonia, highlight potential targets for improved treatment of comorbid chronic pain and depression.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.